Login to Your Account

Merck, Cue pooling efforts in deal valued $374M-plus

By Randy Osborne
Staff Writer

Thursday, November 16, 2017

Cue Biopharma Inc., which in September filed for an IPO to raise up to $40 million, inked a deal with Merck & Co. Inc. that brings an undisclosed up-front payment along with as much as $374 million in research, development, regulatory and commercial milestone payments, plus tiered royalties on sales.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription